MediClin AG (XTER:MED) YoY EBITDA Growth : 14.85% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is MediClin AG YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. MediClin AG's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 14.85%.

MediClin AG's EBITDA per Share for the three months ended in Dec. 2023 was €0.67.

MediClin AG YoY EBITDA Growth Historical Data

The historical data trend for MediClin AG's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediClin AG YoY EBITDA Growth Chart

MediClin AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

149.24

-17.17

10.03

7.45

10.29

MediClin AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															-9.25	-27.05	-1.23	51.95	14.85

MediClin AG YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

MediClin AG's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(2.132	-	1.933)	/	\| 1.933 \|
=	10.29 %

MediClin AG's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(0.665	-	0.579)	/	\| 0.579 \|
=	14.85 %

MediClin AG YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of MediClin AG's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

MediClin AG (XTER:MED) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MediClin AG (XTER:MED) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

MED:Germany MED:Germany

Address

Okenstrasse 27, Offenburg, DEU, 77652

Website

https://www.mediclin.de

MediClin AG is a company engaged in operating hospitals. It is focused on providing services in the areas of neurosciences and psychological sciences as well as orthopedics in Germany. The hospitals are acute-care hospitals providing basic, standard, and specialized care, as well as specialist clinics for medical rehabilitation. The operating segments of the group are Post-acute, Acute and Other activities. It generates majority of the revenue from the Post-acute segment in which the firm offers services in the fields of subsequent nursing treatment and curative treatment. Subsequent nursing treatment starts after acute care treatment and includes all medical measures required to facilitate the healing process and return the patient to a functioning state.